KPV 10mg
$50.00
KPV 10mg is a 99%+ pure research peptide studied for its role in anti-inflammatory response, immune modulation, and gut health pathways. Commonly used in research involving inflammation control and digestive system function. For research use only.
You’re now subscribed to price tracking for this product. We’ll notify you if the price drops.
Fast Delivery
Quick, reliable shipping to any location.
Free Shipping
Free shipping over $300
KPV 10mg is a high-purity research peptide derived from the active fragment of alpha-melanocyte-stimulating hormone (α-MSH), widely studied for its role in anti-inflammatory response, immune modulation, and gut health pathways. This small peptide fragment has gained attention in research for its targeted ability to influence inflammatory signaling without broader systemic effects.
KPV is commonly explored in studies involving inflammation control, gastrointestinal health, and immune system regulation, making it particularly relevant in models focused on conditions related to chronic inflammation and cellular stress. Its mechanism of action is often associated with the modulation of cytokine activity and inflammatory markers, which are key components in many biological processes.
Researchers are especially interested in KPV for its potential to support gut lining integrity, skin health, and localized inflammatory response, leading to its use in studies involving digestive function, dermal repair, and immune balance. Its targeted profile makes it a valuable compound for examining how inflammation impacts overall cellular and systemic health.
This product is supplied as a 99%+ pure lyophilized powder, with 10mg per vial, ensuring stability and consistency for laboratory research. It should be stored at 2°C to 4°C (refrigerated) and handled using proper research protocols to maintain integrity and accurate results.
KPV 10mg is intended strictly for research purposes only. It is not for human consumption, medical use, or diagnostic applications.

Reviews
There are no reviews yet.